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Abstract The Dp71 dystrophin isoform has recently been shown
to localize to actin filament bundles in early myogenesis. We
have identified an actin binding motif within Dp71 that is not
found in other dystrophin isoforms. Actin overlay assays and
transfection of COS-7 cells with fusion proteins of wild type and
mutated Flag epitope-tagged Dp71 demonstrate that this motif is
necessary and sufficient to direct localization of Dp71 to actin
stress fibers. Furthermore, this localization is independent of
alternative splicing which alters the C-terminus of the protein.
The identification of an actin binding site suggests Dp71 may
function to anchor membrane receptors to the cytoskeleton.
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1. Introduction
Duchenne muscular dystrophy (DMD) is caused by muta-
tions in the dystrophin gene [1]. The dystrophin gene encodes
at least seven tissue-speci¢c and developmentally regulated
transcripts which are subject to alternative splicing at the 3P
end, generating a family of isoforms which di¡er in size and
structure [2]. Dystrophin is required to prevent muscle wasting
and is also important for the normal function of the central
nervous system as is evidenced by the mild cognitive impair-
ment and abnormal retinal electrophysiology that is associ-
ated with patients with DMD [2]. The precise function of
dystrophin is unknown. It has been postulated that full length
dystrophin, Dp427, reinforces the muscle membrane by bind-
ing to cytoskeletal actin at the N-terminus and to a trans-
membrane glycoprotein complex at its C-terminus [3]. In
brain and retina two smaller isoforms of dystrophin, Dp260
and Dp71, are required and may be involved in positioning
receptors or channels at specialized sites in the membrane
[4^6]. Distinct patterns of expression and localization of the
dystrophin isoforms are seen in skeletal muscle, heart, brain,
and retina suggesting that the isoforms have di¡erences in
their function which in turn are due to di¡erences in protein
interactions. Thus a complete understanding of the inter-
actions of individual isoforms is necessary to determine the
function of this gene.
We have focussed our e¡orts on the Dp71 isoform since this
isoform is widely expressed and is the most structurally dis-
tinct of all of the isoforms. Dp71 lacks the N-terminal actin
binding domain, rod domain, and WW domain found in full
length dystrophin, but contains a unique seven amino acid N-
terminus fused to the cysteine-rich and C-terminal domains
common to all dystrophin isoforms [7]. Since Dp71 retains
many of the binding sites which in Dp427 are involved in
interactions with the dystrophin-associated glycoprotein com-
plex, it may also interact with members of this complex, pos-
sibly to sequester receptor complexes to speci¢c areas of the
cell membrane. Recently, we have demonstrated that Dp71 is
localized to actin ¢lament bundles in muscle cell culture sys-
tems [8]. The mechanism by which Dp71 localizes to actin
¢lament bundles is enigmatic, since Dp71 does not contain
the actin binding sites found in Dp427. Nevertheless, our re-
sults suggest that Dp71 does interact directly with the actin
cytoskeleton, possibly through one or more unique binding
sites within the N- or C-terminal sequences that are absent
in Dp427.
Here, we investigate the mechanism of Dp71 localization to
actin ¢lament bundles to characterize further the biological
role of Dp71. Our results demonstrate that a hexapeptide
motif within the Dp71 unique N-terminus is necessary and
su⁄cient for the localization of Dp71 to stress ¢bers in
COS-7 cells. These results provide the ¢rst evidence for a
direct interaction between Dp71 and the actin cytoskeleton
and raise important questions regarding the biological role
of Dp71.
2. Materials and methods
2.1. Dp71 constructs
To generate the histidine-tagged Dp71 fusion protein in Escherichia
coli, an EcoRI/StuI fragment containing the N-terminal 1.4 kb of
Dp71 was blunt end ligated into the NdeI site of the vector Pet 25b
(Novagen). The ¢nal product was a chimeric construct containing the
Dp71 N-terminus and a polyhistidine tract at the 3P end. This vector
was transformed into E. coli strain BL-21(DE-3). The fusion protein
containing the Dp71 N-terminus was insoluble, therefore, cells were
harvested by centrifugation, and lysed in cracking bu¡er (6 M urea,
150 mM NaCl, 50 mM Tris (pH 8.0), and 0.01% Triton X-100). The
lysate was incubated on ice for 30 min, sonicated to shear bacterial
genomic DNA, and cleared by centrifugation at 10 000Ug. The super-
natant was incubated with Ni2 agarose beads pre-equilibrated in
cracking bu¡er. The histidine-tagged fusion protein was eluted in
cracking bu¡er containing 250 mM imidazole.
A GFP-Dp71 fusion construct has been previously described [8]. To
place the GFP-Dp71 cDNA under the regulation of the CMV pro-
moter, fragments containing GFP-Dp71 (+exon 71/+exon 78) and
GFP-Dp71 (3exon 71/3exon 78) were isolated from pRcCMV vector
(Invitrogen, California) and ligated into the XbaI site in the adenovi-
rus vector CMV-pvE1Sp1b [9].
PCR ampli¢cation of pBluescript (Stratagene, La Jolla, CA) con-
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taining the full length Dp71 cDNA was used to generate Flag epitope-
tagged wild type and mutant versions of the Dp71 N-terminus. The
primers for the wild type construct were: Fwt: 5P-TCTGAATTCA-
ATGAGGGAACAGCTCAAGGG-3P ; and R1: 5P-TCTGGATCCG-
CAGCTGACAGGCTCAAGAG-3P. For the Dp71(LCA/KCA)-
Flag construct the following primers were used: Fmu: 5P-TCTGA-
ATTCAATGAGGGAACAGGCGGCAGGCCAGG; and R1. The
product of each reaction was separated on a 1.5% agarose gel, isolated
and blunt end ligated into pBluescript. An EcoRI/BamHI insert con-
taining the Dp71 N-terminus was cloned into the pFlagCMV-2 vector
(InterScience, Missisauga, Ont.).
2.2. Actin overlay
Actin was puri¢ed from chicken breast according to the method of
Pardee and Spudich [10]. Fusion proteins (20 Wg) were separated by
SDS-PAGE, and transferred to PVDF membrane. Membranes were
blocked overnight in 1UTBST (50 mM Tris (pH 8.0), 150 mM NaCl,
1% fetal calf serum, and 0.01% Tween-20) with 5% non-fat milk. The
next day, membranes were incubated with 300 ng/ml actin in
1UTBST supplemented with 1 mM MgCl2, and 10 mM ATP, washed
brie£y in 1UTBST, and incubated with a pan-actin monoclonal anti-
body # 4700 (dilution 1:100) (Sigma, St. Louis, MO). Membranes
were washed 3U5 min with 1UTBST and incubated with an anti-
mouse antibody conjugated to horseradish peroxidase (Amersham,
UK). Actin binding was detected using enhanced chemiluminescence
(ECL) according to the manufacturer’s instructions (Amersham, UK).
For the Western blot using antibody Nme-1, the same blot used in the
actin binding experiment was stripped and blocked overnight as in-
dicated above. Antibody Nme-1 has been previously described and is
speci¢c for the ¢rst seven amino acids of the Dp71 N-terminus [5].
The blocked membrane was incubated with antibody Nme-1 (dilution
1:500) in 1UTBST and 1% non-fat milk for 1 h. Fusion proteins
containing the Dp71 N-terminus were detected by ECL as described.
2.3. Cell culture and transfection
COS-7 cells were obtained from the American Tissue Culture Col-
lection (ATCC CRL 1651, Rockville, MD). One day prior to trans-
fection, COS-7 cells were plated at a density of 1000 cells per cm2 into
chamber slides (Nunc, Illinois). Cells were grown in growth medium
(K-MEM 2Uglucose) supplemented with 10% fetal calf serum and
gentamicin (20 Wg/ml) (Gibco BRL, New York). Supercoiled plasmids
were diluted in serum-free media, and introduced into cells using lipo-
fectamine as per the manufacturer’s directions (Gibco BRL). After a
5 h incubation period, the transfection mixture was removed by wash-
ing with growth medium. Cells were maintained in growth medium
for 48 h before being analyzed.
2.4. Immuno£uorescence
COS-7 cells transfected with either pFlagCMV-2, pFlag-Dp71wt, or
pFlag-Dp71mu vectors were washed with PBS U3, and ¢xed for 10
min with cold acetone at 320‡C. The slides were dried and incubated
with primary antibody Flag-M2 (InterScience, Mississauga, Ont.) in
PBS containing 1% fetal calf serum. Cells were washed with PBS and
then incubated for 1 h with secondary goat anti-mouse IgG conju-
gated to biotin (Sigma). Cells were washed with PBS (3U10 min), and
incubated for 1 h with streptavidin conjugated to CY3 (Sigma). Cells
were washed as before, mounted with Immuno£o (ICN, Ohio), and
examined with a Leica epi£uorescent microscope.
2.5. Adenovirus preparation
Recombinant replicative-defective adenoviruses were prepared ac-
cording to the method of Graham and Prevec [9]. Clonal populations
of myogenic cells were isolated from 10 week human fetal muscle
biopsies, as previously described [11]. GFP-Dp71 expression was ex-
amined in cells seeded onto Permanox chamber slides (Nunc, UK) at
high density and allowed to recover for 24 h. To induce myogenic
di¡erentiation, cells were transferred to fusion medium (K-MEM, 16
mM glucose, 2% fetal calf serum and 100 U/ml penicillin and 0.1 mg/
ml streptomycin), and grown for 3^5 days. Fused myotubes were
infected with recombinant adenovirus bearing either GFP-
Dp71(+71/+78) or GFP-Dp71(371/378) at a multiplicity of infection
(MOI) of 100 infectious particles per cell. Cells were maintained in
growth medium for 48 h, washed in PBS, and ¢xed with 3% para-
formaldehyde in PBS for 30 min. Fixed cells were then mounted in
50% glycerol/PBS and analyzed for GFP expression using a Leica
epi£uorescent microscope with a HB103/W mercury lamp and stand-
ard FITC ¢lter set.
2.6. Subcellular fractionation
Liver from C57BL/J6 was harvested and snap frozen in liquid nitro-
gen. Powdered extract was prepared by crushing the frozen sample
using a chilled mortar and pestle. The powdered extract was then
lysed in Triton X-100 lysis bu¡er (2% Triton X-100, 10 mM EGTA,
10 mM Tris-HCl, 2 Wg/ml leupeptin, 10 mM benzamidine, 2 mM
PMSF, pH 7.4) and fractionated as previously described [8]. Dp71
was detected using either antibody Act-1 (1:500 dilution) or antibody
1583 (1:1000 dilution). The preparation of antibody Act-1 and 1583
has been previously described [5,12]. Actin was detected with an anti-
K-actin (A-2172, Sigma). GST-Z was detected using anti-GST-Z (Med-
ical and Biological Laboratories, Nagava, Japan). Primary antibodies
were detected using ECL according to the manufacturer’s instructions
(Amersham, UK).
3. Results
3.1. Actin overlay assay
To investigate whether Dp71 could interact directly with
¢lamentous actin, actin overlay assays were performed on
Dp71 fusion proteins. As shown in Fig. 1, both puri¢ed and
crude extracts of a Dp71 N-terminus-polyhistidine fusion pro-
tein containing the ¢rst 510 amino acids of Dp71 bind actin
¢laments. No actin binding was detected in control lanes con-
taining equal amounts of an unrelated polyhistidine PHR-1
(pleckstrin homology containing protein in the retina) fusion
protein (generous gift from Rahim Ladak) or bovine serum
albumin, suggesting that this interaction is speci¢c. The histi-
dine-tagged Dp71 fusion protein is also recognized by a poly-
clonal antibody speci¢c to the N-terminal seven amino acids
of Dp71, con¢rming that the fusion protein contains an intact
Dp71 N-terminus (Fig. 1c). These results suggested that an
actin binding site is located within the ¢rst 55 kDa of Dp71,
possibly within the unique N-terminus of Dp71.
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Fig. 1. Actin overlay. a: Overlay assay was conducted as described
in Section 2.2. Dp71-histidine fusion protein bound to actin in both
the crude extract (lysate) and puri¢ed eluate lanes. Two additional
lower molecular weight bands were detected in the crude extract
and correspond to truncated products of the full length fusion pro-
tein. b: Negative controls, bovine serum albumin (BSA) (66 kDa)
and a puri¢ed polyhistidine-tagged protein (PHR-1) (28 kDa) were
also probed for actin binding activity using identical conditions. No
actin binding was detected for either protein. c: To con¢rm the
identity of the bands detected in above, the blot used in a was
stripped and probed with antibody Nme-1 speci¢c for the ¢rst seven
amino acids in the Dp71 N-terminus. Nme-1 detected identical
bands corresponding to the full length fusion protein in both the ly-
sate and eluate lanes. Also detected was a band corresponding to
the middle band in the overlay experiment.
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3.2. Actin binding motif within Dp71
A search of the Dp71 primary sequence for protein motifs
which may account for interaction with the actin cytoskeleton
identi¢ed a putative actin binding motif within the Dp71
unique N-terminus (Fig. 2). This motif (LKXXES/T) is
present in several known actin binding proteins and has
been shown to participate in actin binding [13^15]. The critical
residues for actin binding are the conserved leucine and lysine
residues, which have been shown to interact directly with the
N-terminus of actin [14,15]. In most cases, the third and
fourth positions contain a histidine and an alanine residue
followed by a conserved glutamate, and either a serine, or
threonine. In Dp71, the third and fourth positions are occu-
pied by glycine and histidine respectively. As three of the six
residues are encoded by exon one, this actin binding site is
restricted to the Dp71 dystrophin isoform. A search of dys-
trophin primary sequences con¢rmed that this motif is not
present in any other dystrophin isoform.
3.3. Expression of Dp71 N-terminus in COS-7 cells
To test whether the LKGHET motif within the N-terminus
of Dp71 is a functional actin binding site, a eukaryotic ex-
pression vector containing the N-terminus of Dp71 fused to
the Flag peptide (containing the epitope for monoclonal anti-
body Flag M2) was constructed and transfected into COS-7
monkey kidney cells. These cells were chosen for their high
transfection e⁄ciency and because they produce stress ¢bers,
allowing actin co-localization to be readily identi¢ed. As
shown in Fig. 3a,b, a Flag fusion protein containing the
LKGHET motif was targeted to stress ¢bers in COS-7 cells,
and gave a staining pattern that was identical to cells stained
with phalloidin-FITC. In contrast, cells expressing the Flag
epitope alone did not localize to stress ¢bers (Fig. 3c). To
verify that the LKGHET motif is directly responsible for tar-
geting the fusion protein to stress ¢bers, the ¢rst and second
residues of this motif were mutated to alanine residues. These
residues are highly conserved and are known to be involved in
actin binding in the protein actobindin [14,15]. As shown in
Fig. 3d, mutation of these residues abolished the localization
of the fusion protein to stress ¢bers, indicating that the
LKGHET motif within the N-terminus of Dp71 is directly
involved in localizing the protein to stress ¢bers.
3.4. Expression of GFP-Dp71 isoforms
In contrast to full length dystrophin, the majority of endog-
enous Dp71 transcripts in myoblasts undergo splicing which
removes exon 78, and changes the reading frame of the tran-
script, such that a 13 amino acid hydrophilic C-terminus is
replaced with a 31 amino acid primarily hydrophobic C-ter-
minus [8]. Alternative splicing of exon 71 has also been shown
to be a common event in Dp71 transcripts [16]. To investigate
whether alternative splicing of exons 71 or 78 plays a role in
the interaction of Dp71 with actin ¢laments, primary myo-
tubes were transduced with recombinant adenoviruses, ex-
pressing GFP fusion constructs corresponding to either
Dp71 (+exon 71/+exon 78) or Dp71 (3exon 71/3exon 78).
Stress ¢ber-like structure (SFLS) localization was clearly evi-
dent in myotubes expressing either Dp71( +exon 71/+exon 78)
or Dp71 (3exon 71/3exon 78), suggesting that splicing of
exons 71 and 78 does not in£uence actin binding (Fig. 4).
GFP-Dp71 £uorescence was detected along the lengths of
the actin ¢laments and at the ends of the myotubes, where
they adhere to the substrate. This is consistent with our pre-
vious analysis of Dp71 localization in C2C12 cells, and con-
¢rms that Dp71 interacts with SFLS in myogenic cells [8].
3.5. Biochemical fractionation
Actin ¢laments are inherently insoluble in Triton X-100 and
are often su⁄ciently crosslinked that they will pellet under
low centrifugal force [17]. Fig. 5A,B shows Western blots of
Triton X-100 extracts of mouse liver probed with either anti-
body Act-1, which recognizes the hydrophobic carboxy-termi-
nus encoded by exon 79 [5], or antibody 1583, which recog-
nizes the hydrophilic carboxy-terminus encoded by exon 78
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Fig. 3. Transfection of COS-7 cells. COS-7 cells were transfected with either Flag-Dp71wt (a), Flag vector alone (c), or Flag-Dp71mu (LCA/
KCA) (d), and immunostained with the anti-Flag antibody M2. Wild type Flag epitope-tagged Dp71 localized to stress ¢bers and appeared
identical to cells labeled with phalloidin-FITC (b). No actin ¢lament was identi¢able in cells transfected with either Flag vector alone or the
mutated Flag Dp71 construct. Bar = 10 Wm.
Fig. 2. Top: A diagram of the Dp71 protein indicating the position
of the novel N-terminus, cysteine-rich domain, C-terminal domain,
and the alternative C-terminus (ACT) encoded by exon 79. Bottom:
Alignment of Dp71 N-terminus with the LKXXES/T motif present
in many actin binding proteins. In bold are shown the conserved
residues.
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[12]. Both antibodies identi¢ed Dp71 in the low speed pellets,
indicating that Dp71 co-sediments with actin ¢laments. A
GST-Z control included in these experiments demonstrated
that cytosolic proteins fractionated as expected. These experi-
ments con¢rm the results of our GFP-Dp71 expression stud-
ies, and together indicate that the Dp71 dystrophin isoform
associates with actin ¢lament bundles in vivo, and that alter-
native splicing of exons 71 and 78 does not a¡ect this local-
ization.
4. Discussion
We have identi¢ed a binding site for ¢lamentous actin in
the N-terminus of Dp71 that is unique to this isoform of
dystrophin. The site is encoded partially by the novel ¢rst
exon of Dp71, and partially by exon 63 of the dystrophin
gene. The LKGHET motif is very similar to an actin binding
motif originally identi¢ed in the actin binding protein, acto-
bindin, where an LKHAET motif has been shown to form a
direct interaction with actin through the leucine and lysine
residues [13^15]. Several independent lines of evidence indi-
cate that the localization of Dp71 to SFLS occurs through a
direct interaction between the LKGHET motif in the Dp71
N-terminus and actin ¢lament bundles. First, actin overlay
experiments demonstrated that actin binds to the Dp71 N-
terminal fusion proteins containing the motif, but not to con-
trols. Second, addition of the N-terminal 59 residues of Dp71
to the £ag peptide was su⁄cient to target the £ag epitope to
stress ¢bers in COS-7 cells. Third, mutation of the leucine and
lysine residues within the LKGHET motif abolished the co-
localization activity. Finally, Dp71 was shown to co-fraction-
ate with ¢lamentous actin from mouse liver extracts. Taken
together, these results demonstrate that Dp71, like Dp427,
associates with the actin cytoskeleton.
To date, ¢ve actin binding sites (ABS) have been identi¢ed
within the dystrophin gene: ABS1^3 are located within the
¢rst 230 amino acids of Dp427 and are encoded by exons
2^7 [18^21]; ABS4 is located in a section of the rod domain
encoded by exon 56 and is present in both Dp427 and Dp260
[22]. The ¢fth actin binding site, ABS5, is described here. The
only other known protein binding sites in dystrophin lie with-
in the C-terminus of the protein, in a region that is common
to all dystrophin isoforms [23^25]. That three of ¢ve dystro-
phin isoforms (Dp427, Dp260, and Dp71) bind to the actin
cytoskeleton suggests that these isoforms share similar func-
tions. This is contrary to experimental evidence from both in
vitro and in vivo studies indicating that these isoforms exhibit
di¡erences in cellular localization and function [5,8,26,27]. We
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Fig. 5. Western analysis of fractionation. Fractionation of liver ex-
tracts was conducted as described in Section 2.5. A: Antibody 1583
(Dp71 hydrophilic C-terminus). B: Antibody Act-1 (Dp71 hydro-
phobic C-terminus). C: Anti-K-actin. D: Anti-GST-Z. Lane 1, liver
control sample (whole cell lysate) showing migration of Dp71 (ar-
rows). Lane 2, pellet fraction from 15 000Ug spin showing low
speed actin pellet. Lane 3, pellet fraction from 100 000Ug spin
showing high speed pellet. Lane 4, supernatant from ¢nal spin
showing the cytosolic fraction. The majority of Dp71 with either
the hydrophilic C-termini or the hydrophobic C-termini was found
in the low speed pellets and appeared very similar to the distribu-
tion of actin. In contrast, the majority of GST-Z was found in the
cytosolic fraction, indicating non-actin bound cytosolic proteins
fractionated as expected.
Fig. 4. Comparison of GFP-Dp71 isoform expression in primary myotubes. a: A primary myotube expressing GFP-Dp71 (3exon 71/3exon
78). b: A primary myotube expressing GFP-Dp71 (+exon 71/+exon 78). Both GFP-Dp71 chimeric proteins targeted to SFLS (arrows) in pri-
mary myotubes. Bar = 5 Wm.
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have shown that Dp71 occupies a subcellular compartment
that is distinct from Dp427, and in the retina, Dp71 is local-
ized to a cellular layer that is distinct from Dp427 or Dp260
[5,8]. Furthermore, Dp71 does not rescue the muscle pheno-
type in transgenic mdx mice, indicating that Dp71 cannot
functionally replace Dp427 [26,27]. Therefore, although each
of these isoforms associates with actin, di¡erences in protein
interactions mediated by other binding sites within each iso-
form are likely responsible for di¡erences in localization and
function.
Previously, we have shown that an alternatively spliced iso-
form of Dp71 is associated with SFLS in myogenic cells,
suggesting that alternative splicing may in£uence Dp71 iso-
form localization [8]. We have tested by two independent
means whether splicing could a¡ect actin binding and local-
ization to actin ¢lament bundles. GFP-Dp71 fusion proteins
bearing either spliced or unspliced forms of Dp71 localized to
SFLS. Secondly, antisera to either the hydrophilic C-terminus
(1583) or the hydrophobic C-terminus (Act-1) both detected
Dp71 isoforms co-sedimenting with actin. These results sug-
gest that Dp71 actin binding is independent of the splicing of
exons 71 or 78.
The functional signi¢cance of the actin binding site in Dp71
is almost certainly related to the protein interactions occurring
at the C-terminus of the molecule. Recently several dystrophin
interacting proteins have been identi¢ed. The syntrophins (K1,
L1, L2, Q) are a family of proteins that bind to the C-terminal
domain of dystrophin [28^30]. These proteins also contain
additional binding sites, including two pleckstrin homology
(PH) domains, a PDZ domain (post-synaptic density-95
kDa, discs large tumor suppressor protein, zona occludens),
and a syntrophin unique domain, and have been shown to
bind to the cytoplasmic C-termini of the voltage-gated sodium
channels, skm1 and skm2 [31,32]. Although syntrophins, and
by extension dystrophin, are suggested to be involved in the
clustering of these channels, studies of mdx mice transgenic
for mutant Dp427 constructs deleted for syntrophin binding
sites have shown that the interaction is not required for
Dp427 function in muscle [31^33]. The identi¢cation of an
actin binding site within Dp71 suggests that Dp71 may par-
ticipate in the clustering of sodium channels by anchoring the
syntrophin/channel complex to the actin cytoskeleton. This
hypothesis is consistent with recent data showing that Dp71
is required for normal electrophysiology in the neural retina
[5,6], and suggests that loss of Dp71 expression in the retina
may disrupt clustering of retinal-speci¢c ion channels at the
inner limiting membrane. Obviously, identi¢cation of Dp71
interacting proteins will be necessary for understanding the
role of Dp71 in this process.
In summary, we have shown that Dp71 forms a direct in-
teraction with the actin cytoskeleton through a hexapeptide
actin binding motif located in the N-terminus of Dp71. The
identi¢cation of an actin binding site within the N-terminus of
Dp71 provides important insights into the potential role of
this isoform in membrane/protein complexes.
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